The Valley Desk

NCT00085345 · Interventional trial

Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

Overall registry status Withdrawn

Phase 2

Conditions Refractory Plasma Cell Neoplasm, Stage II Multiple Myeloma, Stage III Multiple Myeloma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov